《静脉注射自体活化富血小板血浆疗法对重症和危重症COVID-19患者“促纤维化细胞因子”白细胞介素-1水平的影响：一项初步研究》勘误
Corrigendum to "The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1 Levels in Severe and Critical COVID-19 Patients: A Preliminary Study".
作者信息
Karina Karina, Martin Christoffel Louis, Novariani Rita, Rosadi Imam, Rosliana Iis, Rosidah Siti, Sobariah Siti, Fatkhurohman Novy, Puspitaningrum Nurlaela, Hertati Yuli, Afini Irsyah, Ernanda Difky, Widyastuti Tias, Sulaeha A D, Zakiyah Alfida, Aini Noor, Krisandi Grady, Andrew Hubert
机构信息
Klinik Hayandra, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia.
HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia.
出版信息
Scientifica (Cairo). 2023 Feb 3;2023:9846961. doi: 10.1155/2023/9846961. eCollection 2023.
Abstract
[This corrects the article DOI: 10.1155/2021/9427978.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2021/9427978。]
相似文献
1
Corrigendum to "The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1 Levels in Severe and Critical COVID-19 Patients: A Preliminary Study".《静脉注射自体活化富血小板血浆疗法对重症和危重症COVID-19患者“促纤维化细胞因子”白细胞介素-1水平的影响：一项初步研究》勘误
Scientifica (Cairo). 2023 Feb 3;2023:9846961. doi: 10.1155/2023/9846961. eCollection 2023.
2
The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1 Levels in Severe and Critical COVID-19 Patients: A Preliminary Study.静脉注射自体活化富血小板血浆疗法对重症和危重症COVID-19患者“促纤维化细胞因子”白细胞介素-1水平的影响：一项初步研究。
Scientifica (Cairo). 2021 Jul 8;2021:9427978. doi: 10.1155/2021/9427978. eCollection 2021.
3
Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts.富含血小板的血浆增加了人滑膜成纤维细胞培养物中的基质金属蛋白酶。
J Bone Joint Surg Am. 2012 Dec 5;94(23):e1721-7. doi: 10.2106/JBJS.K.01501.
4
Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.生长因子和分解代谢细胞因子的浓度受富含血小板血浆的细胞成分的影响。
Am J Sports Med. 2011 Oct;39(10):2135-40. doi: 10.1177/0363546511417792. Epub 2011 Aug 16.
5
Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators.富血小板血浆裂解物联合疗法可增加滑膜细胞增殖和透明质酸生成，同时保护软骨细胞免受滑膜细胞衍生的炎症介质影响。
Front Vet Sci. 2018 Jul 4;5:150. doi: 10.3389/fvets.2018.00150. eCollection 2018.
6
Cytokine Profiling and Intra-Articular Injection of Autologous Platelet-Rich Plasma in Knee Osteoarthritis.细胞因子谱分析及膝关节骨关节炎关节内注射自体富血小板血浆。
Int J Mol Sci. 2022 Jan 14;23(2):890. doi: 10.3390/ijms23020890.
7
Corrigendum: Evaluation of a Standardized Protocol for Plasma Rich in Growth Factors Obtention in Cats: A Prospective Study.勘误：猫富含生长因子血浆获取标准化方案的评估：一项前瞻性研究。
Front Vet Sci. 2022 Jun 17;9:954516. doi: 10.3389/fvets.2022.954516. eCollection 2022.
8
Platelet-rich plasma inhibits Wnt/β-catenin signaling in rabbit cartilage cells activated by IL-1β.富血小板血浆抑制白细胞介素-1β激活的兔软骨细胞中的 Wnt/β-连环蛋白信号通路。
Int Immunopharmacol. 2018 Feb;55:282-289. doi: 10.1016/j.intimp.2017.12.031. Epub 2017 Dec 30.
9
Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons.去白细胞富血小板血浆使撕裂的人肩袖肌腱中的基质代谢正常化。
Am J Sports Med. 2015 Dec;43(12):2898-906. doi: 10.1177/0363546515608157. Epub 2015 Oct 12.
10
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients.自体活化富血小板血浆（aaPRP）治疗重症2019冠状病毒病（COVID-19）患者的I/II期临床试验
Int J Inflam. 2021 Jul 7;2021:5531873. doi: 10.1155/2021/5531873. eCollection 2021.
本文引用的文献
1
The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1 Levels in Severe and Critical COVID-19 Patients: A Preliminary Study.静脉注射自体活化富血小板血浆疗法对重症和危重症COVID-19患者“促纤维化细胞因子”白细胞介素-1水平的影响：一项初步研究。
Scientifica (Cairo). 2021 Jul 8;2021:9427978. doi: 10.1155/2021/9427978. eCollection 2021.
Zotero 插件